Massen, G. M., Blamires, O. ., Grainger, M. ., Matta, M. ., Twumasi, R. M. G., Joshi, T. ., … Quint, J. K. (2024). UK Electronic Healthcare Records for Research: A Scientometric Analysis of Respiratory, Cardiovascular, and COVID-19 Publications. Pragmat Obs Res, 15, 151–164. http://doi.org/10.2147/por.s469973
chronic obstructive pulmonary disease
Ozaltin, B. ., Chapman, R. ., Arfeen, M. Q. U., Fitzpatick, N. ., Hemingway, H. ., Direk, K. ., & Jacob, J. . (2024). Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study. Respir Res, 25, 249. http://doi.org/10.1186/s12931-024-02875-2
Tse, G. ., Emmanuel, B. ., Ariti, C. ., Bafadhel, M. ., Papi, A. ., Carter, V. ., … Price, D. . (2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. Int J Chron Obstruct Pulmon Dis, 18, 2565–2580. http://doi.org/10.2147/copd.s433326
Graul, E. L., Nordon, C. ., Rhodes, K. ., Marshall, J. ., Menon, S. ., Kallis, C. ., … Quint, J. K. (2023). Temporal Risk of Non-Fatal Cardiovascular Events Post COPD Exacerbation: A Population-based Study. Am J Respir Crit Care Med. http://doi.org/10.1164/rccm.202307-1122OC
Ismaila, A. S., Rothnie, K. J., Wood, R. P., Banks, V. L., Camidge, L. J., Czira, A. ., … Halpin, D. M. G. (2023). Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respir Res, 24, 229. http://doi.org/10.1186/s12931-023-02523-1
Stone, P. W., Osen, M. ., Ellis, A. ., Coaker, R. ., & Quint, J. K. (2023). Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019. Int J Chron Obstruct Pulmon Dis, 18, 1565–1574. http://doi.org/10.2147/copd.s411739
Raslan, A. S., Quint, J. K., & Cook, S. . (2023). All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD). Int J Chron Obstruct Pulmon Dis, 18, 1207–1218. http://doi.org/10.2147/copd.s407085
Chen, S. ., Miravitlles, M. ., Rhee, C. K., Pavord, I. D., Jones, R. ., Carter, V. ., … Price, D. B. (2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187–2200. http://doi.org/10.2147/copd.s378649
Rothnie, K. J., Joksaite, S. ., Sansbury, L. B., Compton, C. ., Di Boscio, V. ., & Ismaila, A. S. (2022). Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 17, 1455–1466. http://doi.org/10.2147/copd.s338436
Sansbury, L. B., Lipson, D. A., Bains, C. ., Anley, G. A., Rothnie, K. J., & Ismaila, A. S. (2022). Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England. Int J Chron Obstruct Pulmon Dis, 17, 415–426. http://doi.org/10.2147/copd.s336158